‘Avengers: Endgame Encore’ Surpasses Recent Blockbusters in Overseas Presales

Tena Milakovic
avengers endgame encore 1 5
Share:

China’s theatrical market has become increasingly challenging for Hollywood releases, with screening allocations often indicating local distributors’ confidence in a title. Marvel’s latest re-release, however, began with a surprisingly cautious approach.

Initially, ‘Avengers: Endgame Encore’ was limited to fewer than 100 screenings in China during its first two weeks, a modest number for a franchise with Marvel’s box office history in the region. This limited rollout made its subsequent expansion all the more impressive.

Pre-sales for ‘Avengers: Endgame Encore’ surged to 11,000 screenings this Friday, ahead of the film’s re-release in China on September 25, with previews starting on September 24. The re-release has already amassed a pre-sales total of $342,000 for the entire September 24-27 window, placing it ahead of many recent blockbusters in the market.

The $342,000 total is divided across four days, with $126,000 from Thursday, September 24 previews and $195,000 from the opening day on Friday, September 25. The following two days saw a significant drop-off, with $14,000 on Saturday, September 26, and $7,500 on Sunday, September 27.

This steep decline after the opening day likely reflects the natural front-loading of presale tracking rather than a genuine decrease in interest. As screenings continue to be added, later weekend figures have had less time to accumulate before this snapshot was taken.

When compared to the wider 2026 release slate, ‘Endgame Encore’s’ presale performance stands out. It has already outpaced ‘Superman’ at $22,000, ‘F1’ at $36,000, ‘Dune: Part Two’ at $87,000, and the latest ‘Apes’ entry at $91,000 in China presales.

Further down the list, ‘Aquaman 2’ sits at $97,000, ‘The Flash’ at $125,000, and ‘Godzilla x Kong’ at $142,000, all trailing behind Marvel’s re-release. Even ‘The Batman’ at $175,000 and ‘Deadpool and Wolverine’ at $221,000 fall short, leaving only ‘Captain America: Brave New World’s’ $346,000 presale kickoff ahead, with six days remaining before that film’s presale window closes.

The initial limitation of fewer than 100 screenings during the first two weeks stands out, especially considering how quickly momentum built once that ceiling was lifted. The jump to 11,000 screenings indicates that distributors recognized enough demand to justify a much broader release than initially planned.

Such a restricted-then-expanded rollout is not uncommon in the Chinese market, where theatrical allocations can change rapidly based on early audience reactions. With additional screenings expected to be added in the coming days, the presale figures could continue to rise well beyond their current totals.

This re-release is not merely a nostalgia trip. The version being shown in Chinese theaters reportedly includes new footage linked to ‘Avengers: Doomsday,’ positioning ‘Endgame Encore’ as both a promotional bridge to the upcoming sequel and a standalone theatrical event.

This context helps clarify why Marvel and its distribution partners may have pushed for expanded screening access once early demand was evident. With ‘Doomsday’ still months away, giving ‘Endgame’ a renewed theatrical life serves as an extended trailer campaign for one of the studio’s most eagerly awaited upcoming releases.

As screenings continue to be added and the presale window remains open, these figures represent a snapshot rather than a final count. If the current pace holds or accelerates as more theaters come online, ‘Endgame Encore’ could achieve numbers comparable to some of the biggest theatrical comebacks seen in China from legacy blockbusters.

Such results would carry significance beyond mere box office bragging rights. A strong turnout for a re-release closely tied to ‘Doomsday’ marketing would provide Marvel with valuable insights into audience appetite for the franchise’s next chapter before it even debuts in December.

Have something to add? Let us know in the comments.

Share: